Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine–Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis-Reference-Cited by-同舟云学术

Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine–Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis

Published:2021-12-01 Issue:12 Volume:6 Page:1451
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Rizk John G.¹,Gupta Aashish²,Sardar Partha²,Henry Brandon Michael³,Lewin John C.⁴,Lippi Giuseppe⁵,Lavie Carl J.²

Affiliation:

1. Arizona State University, Edson College, Phoenix, Arizona

2. John Ochsner Heart and Vascular Institute, Ochsner Clinical School—The University of Queensland School of Medicine, New Orleans, Louisiana

3. The Heart Institute, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio

4. National Coalition on Health Care, Washington, DC

5. Section of Clinical Biochemistry, University of Verona, Verona, Italy

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

Link

https://jamanetwork.com/journals/jamacardiology/articlepdf/2783051/jamacardiology_rizk_2021_rv_210003_1637772506.3757.pdf

Reference75 articles.

1. Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic.;Rizk;Drug Discov Today,2021

2. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association.;Saposnik;Stroke,2011

3. Cerebral venous thrombosis: an update.;Ferro;Curr Neurol Neurosci Rep,2019

4. Cerebral venous thrombosis.;Silvis;Nat Rev Neurol,2017

5. Diagnosis and management of cerebral venous sinus thrombosis with vaccine-induced immune thrombotic thrombocytopenia.;Furie;Stroke,2021

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID‐19 vaccine adverse events: Evaluating the pathophysiology with an emphasis on sulfur metabolism and endotheliopathy;European Journal of Clinical Investigation;2024-08-08

2. COVID-19 and stroke in women: impact on clinical, psychosocial and research aspects;Neurological Sciences;2024-08-06

3. Cerebral Venous Sinus Thrombosis;Neurosurgery Clinics of North America;2024-07

4. Incidence and management of the main serious adverse events reported after COVID‐19 vaccination;Pharmacology Research & Perspectives;2024-06

5. Developing MiR‐133a Zipper Nanoparticles for Targeted Enhancement of Thermogenic Adipocyte Generation;Advanced Healthcare Materials;2024-05-31